Suppr超能文献

利用计算方法对花粉过敏原Bet v 1进行结构和结合研究的见解。

Insights into structural and binding studies of pollen allergen Bet v 1 using computational approaches.

作者信息

Pandit Mansi, Narayanasamy Nandita, Latha N

机构信息

Bioinformatics Infrastructure Facility, Sri Venkateswara College (University of Delhi), Benito Juarez Road, Dhaula Kuan, New Delhi, 110021 India.

Department of Biochemistry, Sri Venkateswara College (University of Delhi), Benito Juarez Road, Dhaula Kuan, New Delhi, 110021 India.

出版信息

In Silico Pharmacol. 2025 Jan 11;13(1):14. doi: 10.1007/s40203-024-00303-3. eCollection 2025.

Abstract

UNLABELLED

Bet v 1, the European White Birch tree pollen allergen is responsible for a number of allergic responses in humans such as rhinitis, asthma and oral allergy syndrome. The allergen belongs to pathogenesis-related (PR) class 10 protein superfamily and exists in several naturally occurring isoforms. Limited structural information on Bet v 1 isoallergens and variants prompted us to carry out their in silico structural characterization. In this study, three-dimensional structures of Bet v 1 isoallergens were predicted followed by allergen-antibody docking with Bet v 1- specific human IgE. Further, molecular dynamics simulations were performed for the allergen-antibody complexes. In addition, in silico mutagenesis was carried out for the design of a hypoallergenic variant of Bet v 1. Our study aimed to elucidate the differential ability of Bet v 1 isoallergens in eliciting allergic responses based on structural features and also identified a potential hypoallergen allowing us to propose it as a promising candidate for treating birch pollen-induced allergy.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s40203-024-00303-3.

摘要

未标注

欧洲白桦树花粉过敏原Bet v 1会引发人类的多种过敏反应,如鼻炎、哮喘和口腔过敏综合征。该过敏原属于病程相关(PR)10类蛋白超家族,存在多种天然存在的异构体。关于Bet v 1同种过敏原和变体的结构信息有限,促使我们对其进行计算机结构表征。在本研究中,预测了Bet v 1同种过敏原的三维结构,随后将过敏原与Bet v 1特异性人IgE进行抗体对接。此外,对过敏原-抗体复合物进行了分子动力学模拟。此外,还进行了计算机诱变,以设计一种低过敏原性的Bet v 1变体。我们的研究旨在根据结构特征阐明Bet v 1同种过敏原引发过敏反应的差异能力,并确定一种潜在的低过敏原,使我们能够将其作为治疗桦树花粉诱导过敏的有前景的候选物提出。

补充信息

在线版本包含可在10.1007/s40203-024-00303-3获取的补充材料。

相似文献

3
Specific allergen immunotherapy for the treatment of atopic eczema.特异性变应原免疫疗法治疗特应性皮炎
Cochrane Database Syst Rev. 2016 Feb 12;2(2):CD008774. doi: 10.1002/14651858.CD008774.pub2.
4
Sublingual immunotherapy for allergic rhinitis.过敏性鼻炎的舌下免疫疗法。
Cochrane Database Syst Rev. 2003(2):CD002893. doi: 10.1002/14651858.CD002893.
6
Probiotics in infants for prevention of allergic disease.婴儿使用益生菌预防过敏性疾病。
Cochrane Database Syst Rev. 2025 Jun 13;6(6):CD006475. doi: 10.1002/14651858.CD006475.pub3.
8
Allergen-specific oral immunotherapy for peanut allergy.针对花生过敏的过敏原特异性口服免疫疗法。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009014. doi: 10.1002/14651858.CD009014.pub2.

本文引用的文献

2
Birch pollen-The unpleasant herald of spring.桦树花粉——春天令人不悦的先兆。
Front Allergy. 2023 May 15;4:1181675. doi: 10.3389/falgy.2023.1181675. eCollection 2023.
4
EAACI Molecular Allergology User's Guide.欧洲变态反应和临床免疫学会分子变态反应学用户指南
Pediatr Allergy Immunol. 2016 May;27 Suppl 23:1-250. doi: 10.1111/pai.12563.
7
Current overview of allergens of plant pathogenesis related protein families.植物病程相关蛋白家族过敏原的当前概述。
ScientificWorldJournal. 2014 Feb 16;2014:543195. doi: 10.1155/2014/543195. eCollection 2014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验